Hall R I, Grant J P, Ross L H, Coleman R A, Bozovic M G, Quarfordt S H
J Clin Invest. 1984 Nov;74(5):1658-68. doi: 10.1172/JCI111582.
Hepatic steatosis frequently complicates total parenteral nutrition (TPN). Some of the mechanisms responsible were examined in rats receiving calories as dextrose (CHO-TPN) or dextrose plus lipid emulsion (Lipid-TPN). Hepatic triglyceride content increased approximately threefold after CHO-TPN and twofold after Lipid-TPN (P less than 0.02). Hepatic triglyceride fatty acid composition reflected endogenous synthesis. Hepatic acetyl-Coenzyme A carboxylase specific activity increased fourfold after CHO-TPN and twofold after Lipid-TPN, and it correlated positively with hepatic lipid content (r = 0.82). The activities of the microsomal enzymes of complex lipid synthesis were unchanged in the TPN groups. Both TPN regimens suppressed hepatic triglyceride secretion, measured by the rise in plasma triglyceride and the incorporation of [14C]palmitic acid into plasma triglyceride after intravenous Triton. Hepatic triglyceride secretion correlated negatively with total hepatic lipid content (r = -0.89). CHO-TPN increased the uptake of a radiolabeled triglyceride emulsion and increased hepatic lipase activity, whereas Lipid-TPN decreased both. Both adipose and cardiac lipase were higher for Lipid-TPN animals than for CHO-TPN or control animals. Hepatic 14C-triglyceride content was increased in both TPN groups as compared with controls after the injection of 1-[14C]-palmitic acid. This increment was proportional to the decreased hepatic secretion. Triglyceride fatty acid oxidation was significantly suppressed by CHO-TPN, less so by Lipid-TPN. Free fatty acid oxidation was suppressed only by CHO-TPN. The results suggest that the steatosis induced by TPN in rats was due to enhanced hepatic synthesis of fatty acid and reduced triglyceride secretion. Reduced hepatic triglyceride uptake, enhanced fatty acid oxidation, and enhanced peripheral tissue plasma triglyceride lipolysis when CHO-TPN is supplemented with lipid may modulate the accumulation of hepatic triglyceride and, along with reduced synthesis of fatty acid, lead to a lower hepatic triglyceride content.
肝脂肪变性常使全胃肠外营养(TPN)变得复杂。在接受以葡萄糖(CHO-TPN)或葡萄糖加脂质乳剂(Lipid-TPN)形式提供热量的大鼠中,研究了部分相关机制。CHO-TPN后肝甘油三酯含量增加约三倍,Lipid-TPN后增加两倍(P<0.02)。肝甘油三酯脂肪酸组成反映内源性合成。CHO-TPN后肝乙酰辅酶A羧化酶比活性增加四倍,Lipid-TPN后增加两倍,且与肝脂质含量呈正相关(r = 0.82)。TPN组中复合脂质合成的微粒体酶活性未改变。两种TPN方案均抑制肝甘油三酯分泌,这通过静脉注射曲通后血浆甘油三酯升高以及[14C]棕榈酸掺入血浆甘油三酯来衡量。肝甘油三酯分泌与肝总脂质含量呈负相关(r = -0.89)。CHO-TPN增加放射性标记甘油三酯乳剂的摄取并增加肝脂肪酶活性,而Lipid-TPN则使其均降低。与CHO-TPN组或对照组动物相比,Lipid-TPN组动物的脂肪和心脏脂肪酶均更高。注射1-[14C]-棕榈酸后,与对照组相比,两个TPN组的肝14C-甘油三酯含量均增加。这种增加与肝分泌减少成比例。CHO-TPN显著抑制甘油三酯脂肪酸氧化,Lipid-TPN的抑制作用较小。仅CHO-TPN抑制游离脂肪酸氧化。结果表明,TPN诱导大鼠脂肪变性是由于肝脂肪酸合成增强和甘油三酯分泌减少。当CHO-TPN补充脂质时,肝甘油三酯摄取减少、脂肪酸氧化增强以及外周组织血浆甘油三酯脂解增强,可能调节肝甘油三酯的积累,并与脂肪酸合成减少一起导致较低的肝甘油三酯含量。